$ENVB Balance Sheet | Understand Stock

$ENVB

$1.42 +$0.04 (2.9%) Close

$ENVB Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Balance Sheets

In millions of USD, except per-share amounts

	Q2 FY2026 As of Jun 30, 2026	Q1 FY2026 As of Mar 31, 2026	Q4 FY2025 As of Dec 31, 2025	Q3 FY2025 As of Sep 30, 2025	Q2 FY2025 As of Jun 30, 2025	Q1 FY2025 As of Mar 31, 2025	Q4 FY2024 As of Dec 31, 2024	Q3 FY2024 As of Sep 30, 2024	Q2 FY2024 As of Jun 30, 2024	Q1 FY2024 As of Mar 31, 2024	Q4 FY2023 As of Dec 31, 2023	Q3 FY2023 As of Sep 30, 2023	Q2 FY2023 As of Jun 30, 2023	Q1 FY2023 As of Mar 31, 2023	Q4 FY2022 As of Dec 31, 2022	Q3 FY2022 As of Sep 30, 2022	Q2 FY2022 As of Jun 30, 2022	Q1 FY2022 As of Mar 31, 2022	Q4 FY2021 As of Dec 31, 2021	Q3 FY2021 As of Sep 30, 2021
ASSETS
Current assets:
Cash
Prepaid expenses and other current assets
Total current assets
Other assets:
Property and equipment, net
Right-of-use operating lease asset
Intangible assets, net
Deferred offering costs, non-current
Total other assets

Total assets
LIABILITIES, MEZZANINE EQUITY, AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable and accrued liabilities
Accounts payable
Due to related parties
Related Party
Total due to related parties
Accrued liabilities
Current portion of right-of-use operating lease obligation
Investment option liability
Warrant liability
Derivative liability
Accrued expenses and other current liabilities

Total current liabilities

Non-current portion of right-of-use operating lease obligation
Deferred tax liability
Investment option liability
Warrant liability
Total non-current liabilities
Total liabilities
Mezzanine equity
Series C redeemable preferred stock, $0.01 par value, 100,000 shares authorized, and 0 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Redeemable non-controlling interest
Total mezzanine equity
Shareholders’ equity
Common Stock, $0.01 par value, 100,000,000 shares authorized, 3,935,884 and 1,061,533 shares issued and outstanding as of June 30, 2026 and December 31, 2025, respectively
Additional paid-in capital
Stock subscription receivable
Accumulated deficit
Accumulated other comprehensive loss
Total shareholders’ equity
Total liabilities, mezzanine equity, and shareholders’ equity

Comments